Investing in Women, Advancing Healthcare: IIS Partners with Women in Medicine®
IIS partners with Women in Medicine® and contributes $11,000 to support the founding Fellowship cohort of 15 women.
This National Women in Business Month, IIS is shining a spotlight on nine women across our network paving the way forward. Explore Women Leading Infusion Care
Discover exclusive insights from our strategic partners—expertly tailored to provide clarity on the high-priority questions we’ve raised on behalf of the entire IIS member community.
IIS partners with Women in Medicine® and contributes $11,000 to support the founding Fellowship cohort of 15 women.
To mark its 11th year, Infinity Infusion Solutions is recognizing nine women across its network and contributing $11,000 to Women in Medicine® in support of the organization’s inaugural Fellowship.
Infinity Infusion Solutions (IIS) has been named a finalist in D CEO’s 2026 Excellence in Healthcare Awards in the Outstanding Healthcare Organization category.
For community-based infusion providers, the most significant proposals involve changes to physician office drug administration payments under the PFS and a widening disparity between payments to physician offices and freestanding infusion centers and payments to hospital outpatient departments (HOPDs).
Local Infusion was founded in 2023 and has been an Infinity Infusion Solutions member since its launch, with its founders’ relationship with IIS extending back even further. Since then, Local Infusion has grown from approximately a dozen infusion centers to more than 70 locations nationwide, with continued expansion underway. Co-founded by Ashley Knapp, Local Infusion combines patient-centered clinical care with proprietary, AI-driven technology designed to accelerate access to specialty infusion therapy, simplify workflows and improve the experience for patients and care teams.
Stay informed on the 2026 legislative and drug pricing reforms impacting infusion care, from Medicare negotiations to NICA’s active advocacy efforts on Capitol Hill.
Stay ahead of federal drug pricing reforms with a breakdown of President Trump’s MFN initiative, CMS's new GLOBE and GUARD models, and how IPA is navigating these complex changes.
Explore the key takeaways from the 2026 Drug Channels Leadership Forum, covering how 340B complexity, vertical integration, and CMS pricing reforms are reshaping the healthcare landscape.
Read IIS and NICA's legislative and policy update on protecting community infusion care, reimbursement, and patient access.
See how IIS helped a plasma-derived manufacturer grow buy-and-bill infusion therapy adoption across ambulatory infusion sites.
Learn how Medicare's Drug Price Negotiation Program and Maximum Fair Prices may affect Part B infusion reimbursement and patient access.
Read how TwelveStone Health Partners has benefited from IIS contracting, advocacy, and infusion market support.
Learn how IIS's expanded distributor network with Cencora supports member practices, pricing, and infusion operations.
Confidence doesn’t always arrive with a bold entrance. Sometimes, it builds quietly, step by step, as we show up for ourselves day after day.
Confidence doesn’t always arrive with a bold entrance. Sometimes, it builds quietly, step by step, as we show up for ourselves day after day.